ALPHA CF - 53499-0490-2 - (ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT,IPECAC)

Alphabetical Index


Drug Information of ALPHA CF

Product NDC: 53499-0490
Proprietary Name: ALPHA CF
Non Proprietary Name: ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT,IPECAC
Active Ingredient(s): 4; 4; 2; 2; 4; 3; 6    [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 & nbsp;   ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT,IPECAC
Administration Route(s): SUBLINGUAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of ALPHA CF

Product NDC: 53499-0490
Labeler Name: Nature's Way Products, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date: 20040701

Package Information of ALPHA CF

Package NDC: 53499-0490-2
Package Description: 1 BOTTLE, GLASS in 1 BOX (53499-0490-2) > 120 TABLET in 1 BOTTLE, GLASS

NDC Information of ALPHA CF

NDC Code 53499-0490-2
Proprietary Name ALPHA CF
Package Description 1 BOTTLE, GLASS in 1 BOX (53499-0490-2) > 120 TABLET in 1 BOTTLE, GLASS
Product NDC 53499-0490
Product Type Name HUMAN OTC DRUG
Non Proprietary Name ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT,IPECAC
Dosage Form Name TABLET
Route Name SUBLINGUAL
Start Marketing Date 20040701
Marketing Category Name UNAPPROVED HOMEOPATHIC
Labeler Name Nature's Way Products, Inc.
Substance Name ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS
Strength Number 4; 4; 2; 2; 4; 3; 6
Strength Unit [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
Pharmaceutical Classes

Complete Information of ALPHA CF


General Information